Drugs / E-SYNC T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06186401 | Apr 2024 → Dec 2027 expected | glioblastoma | Hideho Okada, MD, PhD | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | E-SYNC T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06186401 ↗ |
| Route | Intravenous | “E-SYNC T cells IV on day 0” NCT06186401 ↗ |